Oncolytics Biotech Inc. (ONCY) Publishes Data Showing Pelareorep Primes Liver Tumors for Immunotherapy

Oncolytics Biotech Inc. reported PNAS-published preclinical data that pelareorep converted immunologically inactive liver tumors to an active state, increasing PD-L1, ICOSL, and CD8+ T cells, potentially enabling response to checkpoint inhibitors.Material DetailsContext by AI AnalystThis is an earl…